PTSM: Pharmaceutical Technology Sourcing and Management
A roundup of the latest developments for drug delivery of parenteral drugs.
Innovation in parenteral drug delivery often comes from the device itself to enable ease of use and greater patient compliance. Several recent developments in parenteral drug delivery involve thin-wall needles for prefilled syringes, an auto-injector with audio and visual functionality, and an improved self-injection system.
Prefilled syringes
In late July, BD Medical, a segment of BD (Becton, Dickinson and Company), launched the BD Hyflow needle, a 27-gauge thin-wall needle designed for use with BD’s prefillable syringe systems. The optimized inner diameter of the BD Hyflow needle enables injection of highly viscous drug formulations without the use of a larger needle that could be more painful for the patient, according to the company.
The BD Hyflow needle increases flow to facilitate use with auto-injectors and infusors. The new needle technology also reduces the pressure required to inject, a crucial attribute for patients with dexterity limitations and facilitates patient use and compliance. The needle technology represents an alternative to larger needle-gauge systems. BD says the product is one of several the company plans to launch over the next 18 months to enhance the performance of prefilled-syringe systems.
Auto-injector with audio and visual functionality
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.